Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice

BJU International

Volumn 109, Issue 4, 2012, Pages 586-593

  Ferrini, Monica G ^a,b   Moon, Joanne ^a   Rivera, Steve ^c   Rajfer, Jacob ^b,c   Gonzalez Cadavid, Nestor F ^b,c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

allopurinol; apoptosis; collagen; decorin; erectile dysfunction; molsidomine; nitric oxide; penis; smooth muscle

Indexed keywords

ALLOPURINOL; DECORIN; GLUCOSE; MOLSIDOMINE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENZYME DEFICIENCY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MOUSE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PENILE FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

ALLOPURINOL; ANIMALS; ANTIOXIDANTS; APOPTOSIS; DECORIN; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FIBROSIS; MALE; MICE; MICE, KNOCKOUT; MOLSIDOMINE; MUSCLE, SMOOTH; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PENIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84857033885     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10397.x     Document Type: Article

References (48)

1. Gonzalez-Cadavid NF, Rajfer J,. Experimental models for Peyronie's disease. Implications for therapy. J Sex Med 2009; 6: 303-13
2. Gonzalez-Cadavid NF,. Mechanisms of penile fibrosis. J Sex Med 2009; 6 (Suppl. 3): 353-62
3. Ferrini MG, Kovanecz I, Sanchez S, et al,. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis. Biol Reprod 2007; 76: 915-23 (Pubitemid 46651233)
4. Kovanecz I, Ferrini MG, Davila HH, Rajfer J, Gonzalez-Cadavid NF,. Pioglitazone ameliorates penile corpora veno-occlusive dysfunction (CVOD) in the aged rat. BJU Int 2007; 100: 867-74 (Pubitemid 47360181)
5. Ahn GJ, Sohn YS, Kang KK, et al,. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats. Int J Impot Res 2005; 17: 134-41. Erratum in: Int J Impot Res 2006; 18: 576 (Pubitemid 40434586)
6. Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF,. Pioglitazone prevents corporal veno-occlusive dysfunction (CVOD) in a rat model of type 2 diabetes melittus. BJU Int 2006; 98: 116-24 (Pubitemid 43885518)
7. Ferrini MG, Kovanecz I, Sanchez S, et al,. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med 2009; 6: 415-28
8. Kovanecz I, Rambhatla A, Ferrini MG, et al,. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction (CVOD) that occurs following cavernosal nerve resection in the rat. BJU Int 2008; 101: 203-10 (Pubitemid 350294044)
9. Kovanecz I, Rambhatla A, Ferrini MG, et al,. Long term sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2007; 100: 867-74
10. Ferrini MG, Davila H, Kovanecz I, Sanchez S, Gonzalez-Cadavid NF Rajfer J,. Long-term continuous treatment with vardenafil prevents fibrosis and preserves smooth muscle content in the rat corpora cavernosa after bilateral cavernosal nerve transection. Urology 2006; 68: 429-35 (Pubitemid 44175524)
11. Jiang R, Chen JH, Jin J, Shen W, Li QM,. Ultrastructural comparison of penile cavernous tissue between hypertensive and normotensive rats. Int J Impot Res 2005; 17: 417-23 (Pubitemid 43093242)
12. Davila HH, Rajfer J, Gonzalez-Cadavid NF,. Corporal veno-occlusive dysfunction in aging rats: evaluation by cavernosometry and cavernosography. Urology 2004; 64: 1261-6 (Pubitemid 39647086)
13. Gonzalez-Cadavid NF, Rajfer J,. The pleiotropic effects of inducible nitric oxide synthase on the physiology and pathology of penile erection. Curr Pharm Des 2005; 11: 4041-6 (Pubitemid 41672475)
14. Davila HH, Magee TR, Rajfer J, Gonzalez-Cadavid NF,. Gene therapy with the inducible nitric oxide synthase (iNOS) cDNA regresses the fibrotic plaque in an animal model of Peyronie's disease. Biol Reprod 2004; 71: 1568-77 (Pubitemid 39403252)
15. Vernet D, Ferrini MG, Valente E, et al,. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 2002; 7: 262-76 (Pubitemid 35365671)
16. Ferrini MG, Davila H, Valente EG,. Gonzalez-Cadavid NF, Rajfer J,equal contributors) Aging-related induction of inducible nitric oxide synthase (iNOS) is vasculo-protective in the arterial media. Cardiovasc Res 2004; 61: 796-805 (Pubitemid 38249479)
17. Ferrini MG, Vernet D, Magee TR, et al,. Antifibrotic role of inducible nitric oxide synthase (iNOS). Nitric Oxide 2002; 6: 283-94 (Pubitemid 34852372)
18. Ferrini MG, Rivera S, Moon J, Vernet D, Rajfer J, Gonzalez-Cadavid NF,. The Genetic Inactivation of Inducible Nitric Oxide Synthase (iNOS) Intensifies Fibrosis and Oxidative Stress in the Penile Corpora Cavernosa in Type 1 Diabetes. J Sex Med 2010; 7: 3033-44
19. Rambhatla A, Kovanecz I, Ferrini M, Gonzalez-Cadavid NF, Rajfer J,. Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review. Int J Impot Res 2008; 20: 30-4
20. Magheli A, Burnett AL,. Erectile dysfunction following prostatectomy: prevention and treatment. Nat. Rev Urol 2009; 6: 415-27
21. Mulhall JP,. Penile rehabilitation following radical prostatectomy. Curr Opin Urol 2008; 18: 613-20
22. Messin R, Dubois C, Famaey JP,. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities. Adv Ther 2008; 25: 1200-14
23. Banasiak W, Wilkins A, Pociupany R, Ponikowski P,. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study. Kardiol Pol 2008; 66: 642-9
24. Messin R, Cerreer-Bruhwyler F, Dubois C, Famaey JP, Géczy J,. Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies. Adv Ther 2006; 23: 107-30
25. Oztürk H, Yaǧmur Y, Buyukbayram H, Dokucu AI, Gurel A,. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach. Eur Surg Res 2002; 34: 285-90
26. Benigni A, Zoja C, Noris M, et al,. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model. Am J Kidney Dis 1999; 33: 746-53 (Pubitemid 29159943)
27. Peters H, Daig U, Martini S, et al,. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. Kidney Int 2003; 64: 509-18 (Pubitemid 36871922)
28. McGill NW,. Management of gout: beyond allopurinol. Intern Med J 2010; 40: 545-53
29. Tsai TF, Yeh TY,. Allopurinol in dermatology. Am J Clin Dermatol 2010; 11: 225-32
30. Jia N, Dong P, Ye Y, Qian C, Dai Q,. Allopurinol Attenuates Oxidative Stress and Cardiac Fibrosis in Angiotensin II-Induced Cardiac Diastolic Dysfunction. Cardiovasc Ther 2011; 29: no. doi: 10.1111/j.1755-5922.2010.00243.x
31. Rajesh M, Mukhopadhyay P, Bátkai S, et al,. Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med 2009; 13: 2330-41
32. Hayashi K, Kimata H, Obata K, et al,. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters. J Card Fail 2008; 14: 238-44 (Pubitemid 351434590)
33. Järvinen TA, Ruoslahti E,. Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci USA 2010; 107: 21671-6
34. Mohan RR, Gupta R, Mehan MK, Cowden JW, Sinha S,. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp Eye Res 2010; 91: 238-45
35. Zhang Z, Wu F, Zheng F, Li H,. Adenovirus-mediated decorin gene transfection has therapeutic effects in a streptozocin-induced diabetic rat model. Nephron Exp Nephrol 2010; 116: e11-21
36. Faust SM, Lu G, Wood SC, Bishop DK,. TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J Immunol 2009; 183: 7307-13
37. Yan W, Wang P, Zhao CX, Tang J, Xiao X, Wang DW,. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways. Hum Gene Ther 2009; 20: 1190-200
38. Li Y, Li J, Zhu J, et al,. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther 2007; 15: 1616-22 (Pubitemid 47289004)
39. Qian A, Meals R, Rajfer J, Gonzalez-Cadavid NF,. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 2004; 64: 399-404 (Pubitemid 39092491)
40. Vicari E, La Vignera S, Condorelli R, Calogero AE,. Endothelial Antioxidant Administration Ameliorates the Erectile Response to PDE5 Regardless of the Extension of the Atherosclerotic Process. J Sex Med 2010; 7: 1247-53
41. Villalba N, Martínez P, Bríones AM, et al,. Differential structural and functional changes in penile and coronary arteries from obese Zucker rats. Am J Physiol Heart Circ Physiol 2009; 297: H696-707
42. Shukla N, Hotston M, Persad R, Angelini GD, Jeremy JY,. The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit. BJU Int 2009; 103: 98-103
43. Tziomalos K, Hare JM,. Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance. Front Biosci 2009; 14: 237-62
44. Jeremy JY, Jones RA, Koupparis AJ, et al,. Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase. Int J Impot Res 2007; 19: 265-80 (Pubitemid 46701453)
45. Evliyaoglu Y, Kayrin L, Kaya B,. Effect of allopurinol on lipid peroxidation induced in corporeal tissue by veno-occlusive priapism in a rat model. Br J Urol 1997; 80: 476-9
46. Sazova O, Kadioǧlu A, Gürkan L, et al,. Intracavernous administration of SIN-1+VIP in an in vivo rabbit model for erectile function. Int J Impot Res 2002; 14: 44-9 (Pubitemid 34188630)
47. von Heyden B, Brock GB, Martinez-Piñeiro L, Lue TF,. Intracavernous injection of linsidomine chlorhydrate in monkeys: lack of toxic effect with long-term use. Eur Urol 1996; 30: 502-5 (Pubitemid 26402076)
48. Ahanchi SS, Tsihlis ND, Kibbe MR,. The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg 2007; 45 (Suppl. A): A64-73